221 related articles for article (PubMed ID: 29091975)
1. Treatment Trends and Outcomes in Healthcare-Associated Pneumonia.
Haessler S; Lagu T; Lindenauer PK; Skiest DJ; Priya A; Pekow PS; Zilberberg MD; Higgins TL; Rothberg MB
J Hosp Med; 2017 Nov; 12(11):886-891. PubMed ID: 29091975
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
[TBL] [Abstract][Full Text] [Related]
3. Health care-associated pneumonia in the intensive care unit: Guideline-concordant antibiotics and outcomes.
Attridge RT; Frei CR; Pugh MJ; Lawson KA; Ryan L; Anzueto A; Metersky ML; Restrepo MI; Mortensen EM
J Crit Care; 2016 Dec; 36():265-271. PubMed ID: 27595461
[TBL] [Abstract][Full Text] [Related]
4. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
[TBL] [Abstract][Full Text] [Related]
5. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia.
Grenier C; Pépin J; Nault V; Howson J; Fournier X; Poirier MS; Cabana J; Craig C; Beaudoin M; Valiquette L
J Antimicrob Chemother; 2011 Jul; 66(7):1617-24. PubMed ID: 21586592
[TBL] [Abstract][Full Text] [Related]
6. Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia.
Webb BJ; Dangerfield BS; Pasha JS; Agrwal N; Vikram HR
Respir Med; 2012 Nov; 106(11):1606-12. PubMed ID: 22917808
[TBL] [Abstract][Full Text] [Related]
7. Guideline-concordant therapy and outcomes in healthcare-associated pneumonia.
Attridge RT; Frei CR; Restrepo MI; Lawson KA; Ryan L; Pugh MJ; Anzueto A; Mortensen EM
Eur Respir J; 2011 Oct; 38(4):878-87. PubMed ID: 21436359
[TBL] [Abstract][Full Text] [Related]
8. Health care-associated pneumonia in haemodialysis patients: clinical outcomes in patients treated with narrow versus broad spectrum antibiotic therapy.
Taylor SP; Taylor BT
Respirology; 2013 Feb; 18(2):364-8. PubMed ID: 23066809
[TBL] [Abstract][Full Text] [Related]
9. Time to Guideline-Based Empiric Antibiotic Therapy in the Treatment of Pneumonia in a Community Hospital: A Retrospective Review.
Erwin BL; Kyle JA; Allen LN
J Pharm Pract; 2016 Aug; 29(4):386-91. PubMed ID: 25601458
[TBL] [Abstract][Full Text] [Related]
10. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
[TBL] [Abstract][Full Text] [Related]
11. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
[TBL] [Abstract][Full Text] [Related]
12. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
Frei CR; Restrepo MI; Mortensen EM; Burgess DS
Am J Med; 2006 Oct; 119(10):865-71. PubMed ID: 17000218
[TBL] [Abstract][Full Text] [Related]
13. Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia.
Rothberg MB; Zilberberg MD; Pekow PS; Priya A; Haessler S; Belforti R; Skiest D; Lagu T; Higgins TL; Lindenauer PK
J Antimicrob Chemother; 2015 May; 70(5):1573-9. PubMed ID: 25558075
[TBL] [Abstract][Full Text] [Related]
14. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.
Webb BJ; Dascomb K; Stenehjem E; Dean N
Respir Med; 2015 Jan; 109(1):1-10. PubMed ID: 25468412
[TBL] [Abstract][Full Text] [Related]
15. Guideline-based antibiotics and mortality in healthcare-associated pneumonia.
Madaras-Kelly KJ; Remington RE; Sloan KL; Fan VS
J Gen Intern Med; 2012 Jul; 27(7):845-52. PubMed ID: 22396110
[TBL] [Abstract][Full Text] [Related]
16. Relevance of healthcare-associated pneumonia for empirical antibiotic therapy in the Netherlands.
Schweitzer VA; van Werkhoven CH; van Heijl I; Smits RF; Boel CHE; Bonten MJM; Postma DF; Oosterheert JJ
Neth J Med; 2018 Nov; 76(9):389-396. PubMed ID: 30465653
[TBL] [Abstract][Full Text] [Related]
17. Prospective open-label randomized comparative, non-inferiority study of two initial antibiotic strategies for patients with nursing- and healthcare-associated pneumonia: Guideline-concordant therapy versus empiric therapy.
Matsuda S; Ogasawara T; Sugimoto S; Kato S; Umezawa H; Yano T; Kasamatsu N
J Infect Chemother; 2016 Jun; 22(6):400-6. PubMed ID: 27062334
[TBL] [Abstract][Full Text] [Related]
18. Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia.
Falcone M; Venditti M; Shindo Y; Kollef MH
Int J Infect Dis; 2011 Aug; 15(8):e545-50. PubMed ID: 21616695
[TBL] [Abstract][Full Text] [Related]
19. Adherence to SATS antibiotic recommendations in patients with community acquired pneumonia in Johannesburg, South Africa.
Mukansi M; Chetty A; Feldman C
J Infect Dev Ctries; 2016 Apr; 10(4):347-53. PubMed ID: 27130995
[TBL] [Abstract][Full Text] [Related]
20. Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia.
Simonetti A; Viasus D; Garcia-Vidal C; Adamuz J; Roset A; Manresa F; Dorca J; Gudiol F; Carratalà J
Clin Microbiol Infect; 2012 Nov; 18(11):1149-55. PubMed ID: 22115052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
